Early research (Phase 1)Study completedNCT01294735
What this trial is testing
Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1)
Who this might be right for
Recurrence of Solid TumorGlioblastoma MultiformeMelanoma
Merck Sharp & Dohme LLC 19